News Focus
News Focus
icon url

ralphey

02/19/21 12:18 PM

#325840 RE: CaptBeer #325838

Excellent summary !!
icon url

Invest83838

02/19/21 1:18 PM

#325848 RE: CaptBeer #325838

Capt, Please send to AMRN

One would think they already know all this

But with this Management Team, ya never know

icon url

couldbebetter

02/19/21 2:52 PM

#325863 RE: CaptBeer #325838

CaptBeer, This is why JT sucks! He never took effective measures to
circumvent this problem...Even now I would bet that many generic Vascepa
scrips are eventually being filled as generic Lovaza. Why? Because the
cost of generic Lovaza is substantially lower than the cost of either
generic or branded Vascepa. So even if the Du-saster is reversed it
still will not make the Lovaza problem go away. The sooner AMRN is
placed into the hands of BP the quicker that competent executives can
effectively handle these problems.
icon url

Whalatane

02/19/21 3:58 PM

#325870 RE: CaptBeer #325838

Capt ... agree , thx for the presentation. JT's idea that he can grow brand V scripts faster than generics ....is obviously not working .
Kiwi
icon url

HinduKush

02/19/21 6:13 PM

#325893 RE: CaptBeer #325838

Elegant analysis Capt Beer
I agree with others here that the enemy is more inappropriate Lovaza prescription/substitution than it is generic Vascepa at this time.
HK